Cognitive enhancers - what we should know about them
نویسندگان
چکیده
منابع مشابه
P-138: What Should We Know about Ethical Problem in ART? A Study of Systematic Review
Background: Advances in medical technology have had major impacts on human reproduction. The development of effective contraceptive methods has reduced unwanted fertility, and the development of a variety of drugs and procedures has, for the first time, permitted women with fertility problems to reasonably expect that they can fulfill their desires to have children. So, The aim of this review a...
متن کاملWhat should we know about the KURTOSIS ?
In various studies on blind separation of sources, one assumes that sources have the same sign of kurtosis. In fact, this assumption seems very strong and in this paper we studied relation between signal distribution and the sign of the kurtosis. A theoretical result has been found in a simple case. However, for more complex distributions, the kurtosis sign cannot be predicted and may change wi...
متن کاملWhat we should know about bifurcation disease.
ith great interest we read the article by Li et al. (1) regarding asomotor functional responses of a conduit coronary artery distal o sirolimus-eluting stents in a porcine model. The researchers tated in the discussion, “. . .most of the drug taken up into cardiac issue was transferred by direct contact with the arterial wall, which ay have served as a reservoir for subsequent transfer via diff...
متن کاملWhat residents know about health care reform and what we should teach them.
PURPOSE We surveyed residents and fellows at the University of Louisville School of Medicine (N = 600) to (1) explore their perceptions and knowledge of issues related to health care business and health care reforms, and (2) seek their input on what instructional content concerning health care business and health care reform they would like to receive and what instruction venue they would pre...
متن کاملWhat every pediatrician should know about liver transplantation
Liver transplantation is the treatment of choice for children with end-stage liver disease. Improvement in outcomes (allograft and patient survival) has led to widespread use of pediatric LT worldwide. This success is due to improvement in patient selection, transplant surgery, anesthesia/postoperative care and immunosuppression management. This review will focus on different aspects of LT whi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Farmacja Polska
سال: 2021
ISSN: 0014-8261
DOI: 10.32383/farmpol/136335